Section 1.3 states that Q7A applies to the manufacture of sterile APIs only up to the point
immediately prior to the APIs being rendered sterile. The actual sterilization of APIs, the
subsequent aseptic manipulations and aseptic filling, packaging and labeling is not addressed by
Q7A. These activities are generally regulated by drug product GMP regulations in the three ICH
regions.
